Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
Editor Note: For more information about this release, please scroll to bottom.
LONDON, June 13, 2014 /PRNewswire/ --
The trading session on Thursday, June 12, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,734.19, down 0.65% and the NASDAQ Composite closed at 4,297.63, down 0.79%. The S&P 500 finished the day 0.71% lower at 1,930.11. The losses were broad based as eight out of the ten sectors finished on a negative note. The S&P 500 Health Care Sector Index finished the day at 688.58, down 0.56%, while the index has advanced 0.10% in the previous three months. Investor-Edge has initiated coverage on the following equities: Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI), Pacific Biosciences of California Inc. (NASDAQ: PACB) and Waters Corp. (NYSE: WAT). Free technical research on REGN, SPPI, PACB and WAT can be downloaded upon signing up at:
Shares in Regeneron Pharmaceuticals Inc. edged 0.07% higher on Thursday, closing the session at $310.47. A total of 0.45 million shares were traded, which was below its three months average volume of 0.92 million shares. The stock moved between $307.92 and $315.62 during the session. Shares in Regeneron Pharmaceuticals Inc. have gained 6.55% in the last one month and 12.80% from the beginning of 2014. However, the company's shares have lost 1.04% in the previous three trading sessions. The company's stock is trading above its 50-day and 200-day moving averages. The stock's 50-day moving average of $297.54 is above its 200-day moving average of $295.32. Moreover, Regeneron Pharmaceuticals Inc.'s stock traded at a PE ratio of 87.91 and has a Relative Strength Index (RSI) of 56.67. Sign up today to read free research on REGN at:
On Thursday, shares in Spectrum Pharmaceuticals Inc. recorded a trading volume of 0.42 million shares, below its three months average volume of 0.88 million shares. The stock finished the day at $8.42, which was 1.75% lower its previous day's closing of $8.57, and registered an intraday range of $8.38 and $8.73. Shares in Spectrum Pharmaceuticals Inc. have fallen by 1.06% in the previous three trading sessions and 4.86% on YTD basis, while the shares have advanced 10.94% in the last one month. Shares in Spectrum Pharmaceuticals Inc. are trading above their 50-day and 200-day moving averages of $7.40 and $8.30, respectively. Furthermore, the company's stock has an RSI of 68.83. Sign up today to read free research on SPPI at:
Shares in Pacific Biosciences of California Inc. fluctuated between $5.62 and $6.11 before ending Thursday's session 4.34% higher at $6.01. The company's stock reported a trading volume of 1.31 million shares, above its three months average volume of 0.68 million shares. Pacific Biosciences of California Inc.'s stock has gained 13.61% over the previous three trading sessions and 36.28% in the last one month. Moreover, the company's shares are up 14.91% on YTD basis. Pacific Biosciences of California Inc.'s stock is trading above its 50-day and 200-day moving averages of $4.69 and $5.08, respectively. Additionally, the company's shares have an RSI of 69.97. Sign up today to read free research on PACB at:
Waters Corp.'s stock declined 0.62% on Thursday, closing the day at $104.43. The stock recorded a trading volume of 0.54 million shares, which was below its three months average volume of 0.64 million shares. The company's stock oscillated between $104.22 and $104.97 during the session. Shares of the company traded at a PE ratio of 21.66. Waters Corp.'s stock has lost 1.01% in the previous three trading sessions and 0.66% in the last one month, although, the stock has advanced 4.43% since the start of this year. Waters Corp.'s shares are trading below their 50-day and 200-day moving averages of $105.14 and $104.56, respectively. Further, the company's stock has an RSI of 58.24. Sign up today to read free research on WAT at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
©2012 PR Newswire. All Rights Reserved.